BACKGROUND: The occurrence of oropharyngeal candidiasis (OPC) in combination with HIV disease progression is a very common phenomenon. However, not all HIV-infected patients develop OPC, even when they progress to low CD4 T-cell counts. Because T-cell immunity is defective in AIDS, the innate defence mechanisms are likely to have a central role in antifungal immunity in these patients. We investigated whether genetic variations in the innate immune genes DECTIN-1, TLR2, TLR4, TIRAP, and CASPASE-12 are associated with the presence of OPC in HIV-infected subjects from East Africa. METHODS: A total of 225 HIV patients were genotyped for several single nucleotide polymorphisms (SNPs), and this was correlated with the occurrence of OPC in these patients. In addition, primary immune cells obtained from individuals with different genotypes were stimulated with Candida albicans, and cytokine production was measured. RESULTS: The analysis revealed that no significant differences in the polymorphism frequencies could be observed, although a tendency toward a protective effect on OPC of the DECTIN-1 I223S SNP was apparent. Furthermore, interferon gamma production capacity was markedly lower in cells bearing the DECTIN-1 SNP I223S. It could also be demonstrated that the 223S mutated form of the DECTIN-1 gene exhibits a lower capacity to bind zymosan. CONCLUSIONS: These data demonstrate that common polymorphisms of TLR2, TLR4, TIRAP, and CASPASE-12 do not influence susceptibility to OPC in HIV-infected patients in East Africa but suggest an immunomodulatory effect of the I223S SNP on dectin-1 function and possibly the susceptibility to OPC in HIV patients.
BACKGROUND: The occurrence of oropharyngeal candidiasis (OPC) in combination with HIV disease progression is a very common phenomenon. However, not all HIV-infectedpatients develop OPC, even when they progress to low CD4 T-cell counts. Because T-cell immunity is defective in AIDS, the innate defence mechanisms are likely to have a central role in antifungal immunity in these patients. We investigated whether genetic variations in the innate immune genes DECTIN-1, TLR2, TLR4, TIRAP, and CASPASE-12 are associated with the presence of OPC in HIV-infected subjects from East Africa. METHODS: A total of 225 HIVpatients were genotyped for several single nucleotide polymorphisms (SNPs), and this was correlated with the occurrence of OPC in these patients. In addition, primary immune cells obtained from individuals with different genotypes were stimulated with Candida albicans, and cytokine production was measured. RESULTS: The analysis revealed that no significant differences in the polymorphism frequencies could be observed, although a tendency toward a protective effect on OPC of the DECTIN-1 I223S SNP was apparent. Furthermore, interferon gamma production capacity was markedly lower in cells bearing the DECTIN-1 SNP I223S. It could also be demonstrated that the 223S mutated form of the DECTIN-1 gene exhibits a lower capacity to bind zymosan. CONCLUSIONS: These data demonstrate that common polymorphisms of TLR2, TLR4, TIRAP, and CASPASE-12 do not influence susceptibility to OPC in HIV-infectedpatients in East Africa but suggest an immunomodulatory effect of the I223S SNP on dectin-1 function and possibly the susceptibility to OPC in HIVpatients.
Authors: J R Arribas; S Hernández-Albujar; J J González-García; J M Peña; A Gonzalez; T Cañedo; R Madero; J J Vazquez; W G Powderly Journal: AIDS Date: 2000-05-26 Impact factor: 4.177
Authors: Bart Ferwerda; Gerben Ferwerda; Theo S Plantinga; Janet A Willment; Annemiek B van Spriel; Hanka Venselaar; Clara C Elbers; Melissa D Johnson; Alessandra Cambi; Cristal Huysamen; Liesbeth Jacobs; Trees Jansen; Karlijn Verheijen; Laury Masthoff; Servaas A Morré; Gert Vriend; David L Williams; John R Perfect; Leo A B Joosten; Cisca Wijmenga; Jos W M van der Meer; Gosse J Adema; Bart Jan Kullberg; Gordon D Brown; Mihai G Netea Journal: N Engl J Med Date: 2009-10-29 Impact factor: 91.245
Authors: Maya Saleh; John P Vaillancourt; Rona K Graham; Matthew Huyck; Srinivasa M Srinivasula; Emad S Alnemri; Martin H Steinberg; Vikki Nolan; Clinton T Baldwin; Richard S Hotchkiss; Timothy G Buchman; Barbara A Zehnbauer; Michael R Hayden; Lindsay A Farrer; Sophie Roy; Donald W Nicholson Journal: Nature Date: 2004-05-06 Impact factor: 49.962
Authors: Tobias Woehrle; Weidong Du; Achim Goetz; Hsin-Yun Hsu; Thomas O Joos; Manfred Weiss; Ute Bauer; Uwe B Brueckner; E Marion Schneider Journal: Cytokine Date: 2008-01-30 Impact factor: 3.861
Authors: Heather R Conti; Fang Shen; Namrata Nayyar; Eileen Stocum; Jianing N Sun; Matthew J Lindemann; Allen W Ho; Justine Hoda Hai; Jeffrey J Yu; Ji Won Jung; Scott G Filler; Patricia Masso-Welch; Mira Edgerton; Sarah L Gaffen Journal: J Exp Med Date: 2009-02-09 Impact factor: 14.307
Authors: Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea Journal: Med Mycol Date: 2012-06-04 Impact factor: 4.076
Authors: Diana C Rosentul; Theo S Plantinga; Marius Farcas; Marije Oosting; Omar J M Hamza; William K Scott; Barbara D Alexander; John C Yang; Gregory M Laird; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart-Jan Kullberg; Andre J A M van der Ven; Melissa D Johnson; Mihai G Netea Journal: Med Mycol Date: 2014-04-08 Impact factor: 4.076
Authors: Laura Marshall; Mohammad Obaidullah; Trista Fuchs; Naomi S Fineberg; Garland Brinkley; Ted R Mikuls; S Louis Bridges; Evan Hermel Journal: Immunogenetics Date: 2014-02-11 Impact factor: 2.846
Authors: Diana C Rosentul; Corine E Delsing; Martin Jaeger; Theo S Plantinga; Marije Oosting; Irene Costantini; Hanka Venselaar; Leo A B Joosten; Jos W M van der Meer; Bertrand Dupont; Bart-Jan Kullberg; Jack D Sobel; Mihai G Netea Journal: Front Microbiol Date: 2014-09-23 Impact factor: 5.640
Authors: Panayiotis D Ziakas; Michael L Prodromou; Joseph El Khoury; Elias Zintzaras; Eleftherios Mylonakis Journal: PLoS One Date: 2013-11-25 Impact factor: 3.240